| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8661717 | International Journal of Cardiology | 2018 | 6 Pages |
Abstract
Based on the current meta-analysis, NOACs and warfarin have comparable efficacy and safety in patients with atrial fibrillation undergoing cardioversion.
Keywords
DCCVNOACTIAVKATEERCTRandomized controlled trialvitamin K antagonistTransesophageal echocardiographytransient ischemic attackmajor bleedingdirect current cardioversionIschemic strokeHemorrhagic strokenon-vitamin K antagonist oral anticoagulantconfidence intervalMeta-analysisAtrial fibrillationodds ratioWarfarincardioversion
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Nelson Telles-Garcia, Khagendra Dahal, Cyrus Kocherla, Gregory Y.H. Lip, Pratap Reddy, Paari Dominic,